Indicators

Markets:

News

State Street SPDR S&P Biotech ETF (NY:XBI)

165.73 +2.35 (+1.44%)

Official Closing Price Updated: 6:30 PM EDT, Aug 21, 2026 Add to My Watchlist

Price and Volume

Volume	10,013,982
Open	164.60
Bid (Size)	165.90 (100)
Ask (Size)	166.10 (500)
Prev. Close	163.38
Today's Range	163.74 - 167.91
52wk Range	88.18 - 169.68
Shares Outstanding	541,500
Dividend Yield	0.17%

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

News headline image

IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy? ↗

August 20, 2026

XBI is up nearly 80% over the past year, but has experienced a much larger maximum drawdown over the past five years. IHE has delivered steadier returns and offers a higher dividend yield.

Via The Motley Fool

News headline image

XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets? ↗

August 19, 2026

XBI's lower fees and 155-stock portfolio contrast sharply with FBT's concentrated 30-holding approach, though FBT has experienced less volatility over the past five years.

Via The Motley Fool

Performance

YTD	+36.4%	+36.4%
1 Month	+7.3%	+7.3%
3 Month	+24.8%	+24.8%
6 Month	+30.8%	+30.8%
1 Year	+85.8%	+85.8%

More News

News headline image

Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? ↗

August 18, 2026

Via The Motley Fool

News headline image

iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond? ↗

August 08, 2026

Via The Motley Fool

News headline image

Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI? ↗

August 03, 2026

Via The Motley Fool

News headline image

Here's How Much $100 Invested In State Street SPDR S&P Biotech ETF 20 Years Ago Would Be Worth Today ↗

July 13, 2026

News headline image

Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026? ↗

July 09, 2026

Via The Motley Fool

News headline image

Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best? ↗

July 05, 2026

Via The Motley Fool

News headline image

The Best Biotech Stocks to Buy in 2026 ↗

June 17, 2026

Via The Motley Fool

News headline image

Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors? ↗

June 17, 2026

Via The Motley Fool

News headline image

3 Longevity ETFs to Buy and Hold (and Hold) ↗

June 08, 2026

News headline image

Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech ↗

June 05, 2026

Via The Motley Fool

News headline image

VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost ↗

May 28, 2026

Via The Motley Fool

News headline image

2 Ways to Play the Big Pharma Patent Cliff ↗

May 15, 2026

News headline image

Small Caps Under Siege: Russell 2000 Enters Correction as Yields Surge

March 23, 2026

Via MarketMinute

News headline image

DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing ↗

March 21, 2026

Via The Motley Fool

News headline image

IBRX Stock Rises Overnight: Retail Bets Anktiva’s NCCN 'Recommended' Tag Will Drive Prescriptions And Insurance Wins ↗

March 17, 2026

News headline image

The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)

March 12, 2026

News headline image

Battered Polaryx Stock Turns Retail-Trader Heads After 70% Surge: What’s Behind The Sudden Interest? ↗

March 11, 2026

News headline image

QURE Stock Edges Up After Hours As Analyst Flags Reduced Regulatory Uncertainty Following Prasad’s FDA Exit ↗

March 10, 2026

News headline image

QURE Stock’s Relentless Rally Continues Today — Here's Why HC Wainwright Is Bullish On uniQure ↗

March 10, 2026

News headline image

QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 ↗

March 09, 2026

News headline image

IBRX Stock Declines Pre-Market — ImmunityBio Resubmits Anktiva Application To FDA With Additional Data ↗

March 09, 2026

News headline image

ALT Stock Drops On Wider-Than-Expected Q4 Loss: Retail Voices Hopes For Deal To Alleviate Cash Concerns ↗

March 05, 2026

News headline image

Why Did CRMD Stock Tumble Over 11% Today? ↗

March 05, 2026

Frequently Asked Questions

Is State Street SPDR S&P Biotech ETF publicly traded?

Yes, State Street SPDR S&P Biotech ETF is publicly traded.

What exchange does State Street SPDR S&P Biotech ETF trade on?

State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange

What is the ticker symbol for State Street SPDR S&P Biotech ETF?

The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange

What is the current price of State Street SPDR S&P Biotech ETF?

The current price of State Street SPDR S&P Biotech ETF is 165.73

When was State Street SPDR S&P Biotech ETF last traded?

The last trade of State Street SPDR S&P Biotech ETF was at 08/21/26 06:30 PM ET

What is the market capitalization of State Street SPDR S&P Biotech ETF?

The market capitalization of State Street SPDR S&P Biotech ETF is 89.74M

How many shares of State Street SPDR S&P Biotech ETF are outstanding?

State Street SPDR S&P Biotech ETF has 90M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.